|
|
Article: Zhangjiang Park and Sundia MediTech establish new drug research platform.
- Article from:
- China Business News
- Article date:
- February 10, 2009
CopyrightCOPYRIGHT 2009 Gale acknowledges Publisher's copyright in the text of the Publication and shall place users of that text on notice of that copyright interest. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Zhangjiang Park and Sundia MediTech establish new drug research platform
Shanghai. February 10. INTERFAX-CHINA - Shanghai Zhangjiang Hi-Tech Park and Sundia MediTech Co. Ltd. have established a new platform that aims to push new drug research and development (R & D), Zhangjiang Park and Sundia MediTech announced on Feb. 7.
According to the announcement, intellectual property right (IPR) holders of new drug research projects can apply for financial grants from Zhangjiang Park via the platform and Sundia MediTech will undertake the projects as a contract research organization (CRO). Following which, IPR holders and Zhangjiang Park will collaborate in ...